Population Pharmacokinetic (PK) Study of Zinforo (Ceftaroline) in Critical Care Patients With Early-onset Pneumonia and Normal or Augmented Renal Clearance
Phase of Trial: Phase I
Latest Information Update: 13 Mar 2019
Price : $35 *
At a glance
- Drugs Ceftaroline fosamil (Primary)
- Indications Gram-negative infections; Gram-positive infections; Methicillin-resistant Staphylococcus aureus infections; Pneumonia
- Focus Pharmacokinetics
- Acronyms CEFTAREA
- 15 Feb 2019 Status changed from recruiting to completed.
- 15 Mar 2017 Status changed from not yet recruiting to recruiting.
- 01 Feb 2017 New trial record